Cytodyn

Developer of humanized monoclonal antibodies for the treatment and prevention of HIV infection

placeVancouver, Washington, United States calendar_todayFounded 2002 groups12 employees language cytodyn.com

Registered entities

Innovation

23 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,913 times.

YearFilings
20144
20154
20165
20173
20186
20196
20206
20217
20224
20233
20243
20252

Social engagement

Social engagement: 3.5K social following, 7 posts in the last 12 months — top quartile of its industry.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Private equity133%
Other / undisclosed133%

Recent activity

26 Jun 2026
Partnership
Natera
18 May 2026
Event
LD Micro Invitational XVI conference platform presentation
21 Apr 2026
Event
AACR
Coming soon